1Q approvals

1Q approvals

CompanyApproval
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)Japan approves Kanuma sebelipase alfa to treat lysosomal acid lipase deficiency (LAL-D)
Amgen Inc. (NASDAQ:AMGN)Japan approves Repatha evolocumab to treat familial hypercholesterolemia or hypercholesterolemia in patients at high risk of cardiovascular events and who do not adequately respond to statins
Bayer AG (Xetra:BAYN) FDA approves Kovaltry octocog alfa to treat hemophilia A in children and adults
Biocon Ltd. (NSE:BIOCON; BSE:BIOCON) / Fujifilm Holdings Corp. (Tokyo:4901) Japan approves Basalog insulin glargine, a biosimilar of diabetes drug Lantus
Biogen Inc. (NASDAQ:BIIB) / Samsung GroupEC approves Benepali etanercept, a biosimilar of Enbrel, from the companies' Samsung Bioepis Co. Ltd. JV to treat rheumatoid arthritis (RA), psoriatic arthritis, non-radiographic axial spondyloarthritis and plaque psoriasis
CSL Ltd. (ASX:CSL)FDA approves Idelvion

Read the full 1142 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE